ATE469653T1 - Inhibitoren der geschmacksrezeptoren zur verwendung in der behandlung von fettleibigkeit und zuckerkrankheit - Google Patents

Inhibitoren der geschmacksrezeptoren zur verwendung in der behandlung von fettleibigkeit und zuckerkrankheit

Info

Publication number: ATE469653T1
Authority: AT; Austria
Prior art keywords: obesity; hydrate; disease; treatment; taste receptor
Prior art date: 2004-09-22

Application number

AT05787236T

Other languages

English (en)

Inventor

Soraya Shirazi-Beechey

Jane Dyer

Original Assignee

Vib Vzw

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-22

Filing date

2005-09-22

Publication date

2010-06-15

2005-09-22 Application filed by Vib Vzw filed Critical Vib Vzw

2010-06-15 Application granted granted Critical

2010-06-15 Publication of ATE469653T1 publication Critical patent/ATE469653T1/de

Links

208000008589 Obesity Diseases 0.000 title abstract 2
201000010099 disease Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
239000003112 inhibitor Substances 0.000 title abstract 2
235000020824 obesity Nutrition 0.000 title abstract 2
108091005708 gustatory receptors Proteins 0.000 title 1
230000000968 intestinal effect Effects 0.000 abstract 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
239000008103 glucose Substances 0.000 abstract 2
239000012190 activator Substances 0.000 abstract 1
150000001720 carbohydrates Chemical class 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
239000003446 ligand Substances 0.000 abstract 1
230000004060 metabolic process Effects 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Cell Biology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Pathology (AREA)
Endocrinology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Analytical Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
General Physics & Mathematics (AREA)
Biotechnology (AREA)
Emergency Medicine (AREA)
Marine Sciences & Fisheries (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT05787236T 2004-09-22 2005-09-22 Inhibitoren der geschmacksrezeptoren zur verwendung in der behandlung von fettleibigkeit und zuckerkrankheit ATE469653T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04077610		2004-09-22
PCT/EP2005/054760 WO2006032693A1 (en)	2004-09-22	2005-09-22	Intestinal epithelial glucose sensor

Publications (1)

Publication Number	Publication Date
ATE469653T1 true ATE469653T1 (de)	2010-06-15

Family

ID=35457669

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05787236T ATE469653T1 (de)	2004-09-22	2005-09-22	Inhibitoren der geschmacksrezeptoren zur verwendung in der behandlung von fettleibigkeit und zuckerkrankheit

Country Status (7)

Country	Link
US (1)	US20090196878A1 (de)
EP (1)	EP1802324B1 (de)
AT (1)	ATE469653T1 (de)
AU (1)	AU2005286494B2 (de)
CA (1)	CA2577632C (de)
DE (1)	DE602005021667D1 (de)
WO (1)	WO2006032693A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2215474A4 (de)	2007-07-16	2012-07-18	Avaxia Biologics Inc	Antikörpertherapie zur modulation der funktion von darmrezeptoren
WO2009046168A1 (en)	2007-10-02	2009-04-09	Avaxia Biologics, Inc.	Antibody therapy for use in the digestive tract
US8163704B2 (en)	2009-10-20	2012-04-24	Novartis Ag	Glycoside derivatives and uses thereof
US10849938B2 (en)	2017-09-13	2020-12-01	ZBiotics Company	Gene expression system for probiotic microorganisms
GB201804816D0 (en) *	2018-03-26	2018-05-09	Anglia Ruskin Univ Higher Education Corporation	Cancer treatment

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4642240A (en) *	1982-09-30	1987-02-10	General Foods Corporation	Foodstuffs containing 3-aminobenzesulfonic acid as a sweetener inhibitor
GB8309855D0 (en) *	1983-04-12	1983-05-18	Tate & Lyle Plc	Flavour modifiers
US4544565A (en) *	1984-03-29	1985-10-01	General Foods Corporation	Foodstuffs containing sweetness inhibiting agents
US4910031A (en) *	1988-12-19	1990-03-20	Frito-Lay, Inc.	Topped savory snack foods
JPH07184548A (ja) *	1993-12-28	1995-07-25	Meiji Seito Kk	口腔用組成物
US7803982B2 (en) *	2001-04-20	2010-09-28	The Mount Sinai School Of Medicine Of New York University	T1R3 transgenic animals, cells and related methods
FR2825236B1 (fr) *	2001-05-30	2004-10-15	Lmd	Composition orale comprenant un extrait d'ecorce d'albissia myriophylla et son utilisation pour supprimer ou reduire la fonction gustative
US7115284B2 (en) *	2003-08-11	2006-10-03	Ayurvedic-Life International, Llc	Compositions for diabetes treatment and prophylaxis
US20050244810A1 (en) *	2003-09-29	2005-11-03	Egan Josephine M	Taste signaling in gastrointestinal cells
AU2005247858A1 (en) *	2004-04-14	2005-12-08	Monell Chemical Senses Center	Taste receptors of the T1R family from domestic dog
CA2636447A1 (en) *	2006-01-25	2007-08-02	Vib Vzw	Method to control body weight

2005
- 2005-09-22 DE DE602005021667T patent/DE602005021667D1/de not_active Expired - Lifetime
- 2005-09-22 WO PCT/EP2005/054760 patent/WO2006032693A1/en not_active Ceased
- 2005-09-22 AU AU2005286494A patent/AU2005286494B2/en not_active Ceased
- 2005-09-22 US US11/663,540 patent/US20090196878A1/en not_active Abandoned
- 2005-09-22 EP EP05787236A patent/EP1802324B1/de not_active Expired - Lifetime
- 2005-09-22 AT AT05787236T patent/ATE469653T1/de not_active IP Right Cessation
- 2005-09-22 CA CA2577632A patent/CA2577632C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2006032693A1 (en)	2006-03-30
EP1802324B1 (de)	2010-06-02
US20090196878A1 (en)	2009-08-06
AU2005286494B2 (en)	2011-06-23
DE602005021667D1 (de)	2010-07-15
CA2577632C (en)	2014-04-01
CA2577632A1 (en)	2006-03-30
EP1802324A1 (de)	2007-07-04
AU2005286494A1 (en)	2006-03-30

Similar Documents

Publication	Publication Date	Title
MA32872B1 (fr)	2011-12-01	Traitement du diabete chez des patients dont la regulation glycemique est insuffisante malgre une therapie par un medicament antidiabetique oralou non oral
WO2008008286A3 (en)	2008-04-24	Substituted pyrazoles as ghrelin receptor antagonists
IL194237A0 (en)	2009-09-22	Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
ATE432693T1 (de)	2009-06-15	Kombinationstherapie zur behandlung von diabetes und dadurch bedingten leiden sowie zur behandlung von mittels erhöhung des glp-1-spiegels im blut verbesserten leiden
EA201100266A1 (ru)	2011-10-31	Диокса-бицикло[3.2.1]октан-2,3,4-триольные производные
MX2009003305A (es)	2009-05-28	Inhibidores de co-transportador de glucosa de sodio 2 y metodo para su uso.
DE602004009295D1 (de)	2007-11-15	1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie
MY153198A (en)	2015-01-29	Inhibitors of protein aggregation
MX2009003658A (es)	2009-04-22	Compuestos heterociclicos que contienen nitrogeno biciclico para utilizarse como inhibidores de desaturasa de estearoilo-coa.
MX2009011359A (es)	2009-11-05	Derivados de pirimidinona y sus metodos de uso.
SG163600A1 (en)	2010-08-30	Methods for the treatment of muscle loss
ATE552031T1 (de)	2012-04-15	Pharmazeutische zusammensetzungen enthaltend nicht-acyliertes ghrelin zur behandlung von insulinresistenz
TW200635878A (en)	2006-10-16	Hydroxybiphenylcarboxylic acids and derivatives, processes for preparing them and their use
WO2007120718A3 (en)	2008-07-24	Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
WO2007120688A3 (en)	2008-07-17	Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
ATE438623T1 (de)	2009-08-15	Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes
MX2009004112A (es)	2009-05-11	Imidazoles sustituidos como moduladores del receptor de bombesina subtipo-3.
ATE484506T1 (de)	2010-10-15	Substituierte diazepin-sulfonamide als bombesin- rezeptor-subtyp-3-modulatoren
TW200616985A (en)	2006-06-01	Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use
ATE469653T1 (de)	2010-06-15	Inhibitoren der geschmacksrezeptoren zur verwendung in der behandlung von fettleibigkeit und zuckerkrankheit
DE502006006466D1 (de)	2010-04-29	Eisen(iii) komplex-verbindungen zur oralen behandlung von eisenmangel bei patienten mit chronischen entzündlichen darmerkrankungen
WO2005115446A3 (en)	2007-01-18	Detection and use of prolylcarboxypeptidase
TW200621732A (en)	2006-07-01	Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
DE602004010691D1 (de)	2008-01-24	Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
EP1882474A4 (de)	2008-07-09	Prophylaktisches/therapeutisches mittel für abweichungen im zucker/fettstoffwechsel

Legal Events

Date	Code	Title	Description
2010-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties